A One Health Perspective on Salmonella enterica Serovar Infantis, an Emerging Human Multidrug-Resistant Pathogen

Emerg Infect Dis. 2024 Apr;30(4):701-710. doi: 10.3201/eid3004.231031.

Abstract

Salmonella enterica serovar Infantis presents an ever-increasing threat to public health because of its spread throughout many countries and association with high levels of antimicrobial resistance (AMR). We analyzed whole-genome sequences of 5,284 Salmonella Infantis strains from 74 countries, isolated during 1989-2020 from a wide variety of human, animal, and food sources, to compare genetic phylogeny, AMR determinants, and plasmid presence. The global Salmonella Infantis population structure diverged into 3 clusters: a North American cluster, a European cluster, and a global cluster. The levels of AMR varied by Salmonella Infantis cluster and by isolation source; 73% of poultry isolates were multidrug resistant, compared with 35% of human isolates. This finding correlated with the presence of the pESI megaplasmid; 71% of poultry isolates contained pESI, compared with 32% of human isolates. This study provides key information for public health teams engaged in reducing the spread of this pathogen.

Keywords: One Health; Salmonella enterica serovar Infantis; antimicrobial resistance; bacteria; eBG31; multidrug resistance; pESI.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Drug Resistance, Multiple, Bacterial / genetics
  • Humans
  • One Health*
  • Poultry
  • Salmonella / genetics
  • Salmonella enterica*
  • Serogroup

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Salmonella enterica subsp. enterica